Results of a Prospective Phase II Trial With Ofatumumab as Part of Reduced Intensity Conditioning Regimen in High-Risk Non-Hodgkin B Lymphoma Patients: A GELTAMO Trial

Hematological Oncology - United Kingdom
doi 10.1002/hon.2439_96
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Phase II Study of Yttrium-90-Ibritumomab Tiuxetan as Part of Reduced-Intensity Conditioning (With Melphalan, Fludarabine ± Thiotepa) for Allogeneic Transplantation in Relapsed or Refractory Aggressive B Cell Lymphoma: A GELTAMO Trial

Biology of Blood and Marrow Transplantation
TransplantationHematology
2017English

Dose-Escalated Radioimmunotherapy as Part of Reduced Intensity Conditioning for Allogeneic Transplantation in Patients With Advanced High-Grade Non-Hodgkin Lymphoma

Bone Marrow Transplantation
TransplantationHematology
2012English

Long-Term Outcome of Patients With Relapsed/Refractory B-Cell Non- Hodgkin Lymphoma Treated With Bispecific Antibody Blinatumomab in a Phase I Trial

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Bendamustine as Part of Conditioning Regimen for Autologous Stem-Cell Transplantation in Patients With Aggressive Lymphomas: Final Analysis of a Phase 2 Study From Geltamo

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Nitroglycerin as a Radiosensitizer in Non-Small Cell Lung Cancer: Results of a Prospective Imaging-Based Phase II Trial

Clinical and Translational Radiation Oncology
Nuclear MedicineRadiologyImagingOncology
2020English

A PHASE 2 CLINICAL TRIAL OF RITUXIMAB AND Β-Glucan PGG IN RELAPSED/REFRACTORY INDOLENT B-Cell NON-HODGKIN LYMPHOMA

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

A Phase II Study of Bendamustine in Combination With Rituximab as Initial Treatment for Patients With Indolent Non-Follicular Non-Hodgkin Lymphoma

Leukemia and Lymphoma
Cancer ResearchOncologyHematology
2016English

Evaluation of Bone Marrow Infiltration by Multidimensional Flow Cytometry in Patients With Diffuse Large B-Cell Lymphoma: Sub-Study of a Phase 2 Geltamo Clinical Trial

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Combination of Chidamide With Choep Regimen in Previously Untreated Patients With Peripheral T-Cell Lymphoma: A Prospective, Multicenter, Single-Arm, Phase 1b/2 Trial

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy